Pizzie Nick
SEC CIK 1742143 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| AXSM | Axsome Therapeutics, Inc. | CFO | 75.9K | $33.7K | $12.13M | 8 | 2021-11-18 | 2026-06-09 |
Most active insiders at AXSM, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | TABUTEAU HERRIOT | CEO, Dir, 10% | — | $103.22M |
| 2 | Pizzie Nick | CFO | — | $10.18M |
| 3 | Jacobson Mark L. | COO | — | $8.90M |
| 4 | Coleman Mark | Dir | — | $8.21M |
| 5 | Saad Mark E | Dir | — | $6.21M |
| 6 | Maizel Ari | Chief Commercial Off | — | $2.75M |
| 7 | Mahony Susan | Dir | — | $145.0K |
| 8 | JEFFS ROGER | Dir | — | $141.7K |
Transactions 8
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-06-09 17:17 | 2026-06-09 | AXSM | Axsome Therapeutics, Inc. | Pizzie Nick | CFO | M - OptEx | $3.50 | +33.0K | 75.9K | +77% | +$115.5K |
| DT | 2026-06-09 17:17 | 2026-06-09 | AXSM | Axsome Therapeutics, Inc. | Pizzie Nick | CFO | S - Sale+OE | $240.09 | -33.0K | 42.9K | -43% | -$7.92M |
| DT | 2026-01-23 | 2026-01-22 | AXSM | Axsome Therapeutics, Inc. | Pizzie Nick | CFO | M - OptEx | $3.50 | +12.0K | 54.6K | +28% | +$42.0K |
| DT | 2026-01-23 | 2026-01-22 | AXSM | Axsome Therapeutics, Inc. | Pizzie Nick | CFO | S - Sale+OE | $187.92 | -12.0K | 42.6K | -22% | -$2.26M |
| DMT | 2025-02-14 | 2025-02-13+ | AXSM | Axsome Therapeutics, Inc. | Pizzie Nick | CFO | M - OptEx | $3.50 | +15.0K | 45.2K | +50% | +$52.5K |
| DMT | 2025-02-14 | 2025-02-13+ | AXSM | Axsome Therapeutics, Inc. | Pizzie Nick | CFO | S - Sale+OE | $130.10 | -15.0K | 42.2K | -26% | -$1.95M |
| 2021-11-22 | 2021-11-18 | AXSM | Axsome Therapeutics, Inc. | Pizzie Nick | CFO | P - Purchase | $35.50 | +527 | 41.8K | +1% | +$18.7K | |
| MI | 2021-11-22 | 2021-11-18 | AXSM | Axsome Therapeutics, Inc. | Pizzie Nick | CFO | P - Purchase | $34.97 | +428 | 201 | New | +$15.0K |
Purchase Sale Sale after option exercise All abbreviations